The Current Ratio as of November 2024 (TTM) for Compass Therapeutics, Inc. (CMPX) is 40.74

According to Compass Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 40.74. This represents a change of 68.36% compared to the average of 24.20 of the last 4 quarters.

Compass Therapeutics, Inc. (CMPX) Historical Current Ratio (quarterly & annually)

How has CMPX Current Ratio performed in the past?

The mean historical Current Ratio of Compass Therapeutics, Inc. over the last ten years is 10.03. The current 40.74 Current Ratio has changed 40.50% with respect to the historical average. Over the past ten years (40 quarters), CMPX's Current Ratio was at its highest in in the March 2024 quarter at 40.74. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Compass Therapeutics, Inc. (CMPX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Compass Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compass Therapeutics, Inc. (CMPX) Average Current Ratio

How has CMPX Current Ratio performed in the past?

The current Current Ratio of Compass Therapeutics, Inc. (CMPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Compass Therapeutics, Inc. (CMPX) Current Ratio vs. Peers

How is CMPX’s Current Ratio compared to its peers?

Compass Therapeutics, Inc.’s Current Ratio is greater than IDEAYA Biosciences, Inc. (22.93), greater than AnaptysBio, Inc. (10.23), greater than MeiraGTx Holdings plc (2.34), greater than Keros Therapeutics, Inc. (19.03), greater than Homology Medicines, Inc. (4.19), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than NewAmsterdam Pharma Company N.V. (10.61), greater than Inventiva S.A. (0.96), greater than Cullinan Oncology, Inc. (24.46), greater than PepGen Inc. (8.47), greater than Tyra Biosciences, Inc. (29.55), greater than Vigil Neuroscience, Inc. (3.72), greater than PureTech Health plc (3.68), greater than Aerovate Therapeutics, Inc. (8.78), greater than Enliven Therapeutics, Inc. (17.44), greater than MoonLake Immunotherapeutics (25.51), greater than Structure Therapeutics Inc. (27.63), greater than Replimune Group, Inc. (10.11), greater than Nuvectis Pharma, Inc. (2.74), greater than Lyra Therapeutics, Inc. (3.64), greater than Kronos Bio, Inc. (8.32), greater than Gossamer Bio, Inc. (6.74),

Build a custom stock screener for Compass Therapeutics, Inc. (CMPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compass Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compass Therapeutics, Inc. (CMPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compass Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.